Holen Sie sich die Stockscreener-App
2.36
2.48%
-0.06
Handel nachbörslich:
2.36
Schlusskurs vom Vortag:
$2.42
Offen:
$2.41
24-Stunden-Volumen:
471.09K
Relative Volume:
0.29
Marktkapitalisierung:
$334.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.47M
KGV:
-4.1404
EPS:
-0.57
Netto-Cashflow:
$-124.27M
1W Leistung:
+5.36%
1M Leistung:
+0.43%
6M Leistung:
-36.73%
1J Leistung:
+42.17%
1-Tages-Spanne:
$2.33
$2.48
1-Wochen-Bereich:
$2.10
$2.535
52-Wochen-Spanne:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
Firmenname
Prokidney Corp
Sektor
Branche
Telefon
336-999-7028
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Vergleichen Sie PROK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
2.36 | 342.54M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-06-30 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-10 | Eingeleitet | Guggenheim | Buy |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-25 | Eingeleitet | BTIG Research | Buy |
| 2022-12-21 | Eingeleitet | Jefferies | Buy |
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Eingeleitet | UBS | Buy |
| 2022-10-14 | Eingeleitet | Citigroup | Buy |
| 2022-09-23 | Eingeleitet | BofA Securities | Buy |
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Prokidney Corp Aktie (PROK) Neueste Nachrichten
Why ProKidney Corp. stock could benefit from AI revolutionPortfolio Gains Summary & Fast Gain Stock Tips - ulpravda.ru
Is ProKidney Corp. stock supported by strong fundamentalsEarnings Growth Summary & Weekly Market Pulse Alerts - ulpravda.ru
3 Penny Stocks With Market Caps Under $700M - simplywall.st
Is ProKidney Corp. stock a buy on dipsDouble Top/Bottom Patterns & Rapid Profit Growth - ulpravda.ru
ProKidney (NASDAQ:PROK) Trading 6.9% HigherTime to Buy? - MarketBeat
ProKidney Corp. CEO Bruce Culleton to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
ProKidney Corp. (NASDAQ:PROK) Given Consensus Rating of "Hold" by Analysts - MarketBeat
ProKidney Shares Dip Following FDA Agreement on Rilparencel Approval Strategy - MSN
ProKidney (NASDAQ:PROK) Shares Down 7.3%Should You Sell? - MarketBeat
B of A Securities Downgrades ProKidney (PROK) - MSN
PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study - MSN
ProKidney Corp. (PROK) positioned to redefine chronic kidney disease treatment, believes HC Wainwright - MSN
ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright - Yahoo Finance
ProKidney (PROK) price target increased by 15.10% to 6.85 - MSN
ProKidney (PROK) Price Target Increased by 15.10% to 6.85 - Nasdaq
Is ProKidney Corp. stock attractive for growth ETFsWeekly Trade Recap & Weekly High Momentum Picks - Улправда
Will ProKidney Corp. stock maintain momentum in 2025Weekly Trend Recap & Weekly Momentum Stock Picks - Улправда
Is ProKidney Corp. stock attractive for passive investors2025 Trade Ideas & AI Driven Price Forecasts - Улправда
ProKidney (NASDAQ:PROK) Stock Price Down 4.3%What's Next? - MarketBeat
Will ProKidney Corp. stock outperform tech sector in 20252025 Performance Recap & Smart Swing Trading Alerts - DonanımHaber
Aug Breakouts: Is ProKidney Corp. stock a buy on dips2025 Top Decliners & High Return Trade Opportunity Guides - Улправда
HC Wainwright Weighs in on ProKidney FY2025 Earnings - MarketBeat
ProKidney initiated with a buy at HC Wainwright - MSN
ProKidney (NASDAQ:PROK) Stock Price Up 5.2%What's Next? - MarketBeat
ProKidney (NASDAQ:PROK) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Truliant, ProKidney sales top Triad commercial transactions for week of Dec. 12 - The Business Journals
HC Wainwright & Co. Initiates Coverage of ProKidney (PROK) with Buy Recommendation - Nasdaq
H.C. Wainwright initiates ProKidney stock with Buy rating, $12 target By Investing.com - Investing.com South Africa
ProKidney initiated with a Buy at H.C. Wainwright - TipRanks
HC Wainwright & Co. Initiates Coverage on ProKidney (PROK) with a Buy Rating | PROK Stock News - GuruFocus
HC Wainwright Initiates Coverage on ProKidney With Buy Rating, $12 Price Target - marketscreener.com
H.C. Wainwright initiates ProKidney stock with Buy rating, $12 target - Investing.com India
This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Sahm
ProKidney Corp. (NASDAQ:PROK) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
ProKidney (NASDAQ:PROK) Trading Down 6.8%What's Next? - MarketBeat
Why ProKidney Corp. stock remains resilientJuly 2025 Earnings & Real-Time Volume Analysis - Newser
Promising Penny Stocks To Watch In December 2025 - simplywall.st
What drives ProKidney Corp stock priceCurrency Fluctuation Impact & Rapid Capital Trading Tips - earlytimes.in
ProKidney site sells Greensboro site for $6.5M less than it paid for property - The Business Journals
While insiders own 18% of ProKidney Corp. (NASDAQ:PROK), retail investors are its largest shareholders with 50% ownership - Yahoo Finance
ProKidney Corp. (PROK) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How ProKidney Corp. stock benefits from tech adoptionWeekly Volume Report & Smart Money Movement Alerts - newser.com
Will ProKidney Corp. stock beat EPS estimatesMarket Rally & Free Risk Controlled Daily Trade Plans - newser.com
What data driven models say about ProKidney Corp.’s futureQuarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
What technical charts say about ProKidney Corp. stockJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):